Question 1

What are the potential benefits of combining Alimta and Epirubicin for my type of breast cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer clinical trial (NCT00097383). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer clinical trial (NCT00097383). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination of drugs?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer clinical trial (NCT00097383). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer clinical trial (NCT00097383). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of support will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer clinical trial (NCT00097383). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific dietary or lifestyle changes I should consider while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer clinical trial (NCT00097383). Contact the study team or your healthcare provider for specific answers.

What this study is about